Crossmark

Biomedical nanomaterials for immunological applications: ongoing research and clinical trials

Crossref DOI link: https://doi.org/10.1039/d0na00478b

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Lenders, Vincent https://orcid.org/0000-0001-9775-3655
Koutsoumpou, Xanthippi https://orcid.org/0000-0001-5214-4303
Sargsian, Ara https://orcid.org/0000-0001-6737-649X
Manshian, Bella B. https://orcid.org/0000-0002-3402-3927
Funding

Funding for this research was provided by:

Fonds Wetenschappelijk Onderzoek (G0B2919N)

H2020 European Research Council (ERC StG 750973)

KU Leuven (C24/18/101)
License Information

Version of Record valid from 2020-08-24
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Vincent Lenders (ORCID)

: Xanthippi Koutsoumpou (ORCID)

: Ara Sargsian (ORCID)

: Bella B. Manshian (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 12 June 2020; Accepted 22 August 2020; Accepted Manuscript published 24 August 2020; Advance Article published 8 September 2020; Version of Record published 11 November 2020